$71.92▾ 1.82%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
Fair value
Undervalued
Trading about 57% below our fair-value range
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
ANI Pharmaceuticals, Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
ANI Pharmaceuticals' CFO Sold $285,000 in Stock After a 32% Run